Clinical potential of CDK4/6 inhibitors in breast cancer (Part 2)
• Acquired CDK4/6 inhibitor resistance and what can be done better?
• Toxicities to the drugs, adverse events, and the impact on the quality of life of the patient when they adhere to treatment plans
Clinical potential of CDK4/6 inhibitors in breast cancer (Part 1)
• Mechanism of action of CDK4/6 inhibitors and the complex effects within breast cancers/alteration of tumor biology
• Overview of how the efficacies can be enhanced through novel therapeutic combinations
CDK4/6 inhibitors in invasive disease-free survival of breast cancer patients
• Diagnosis and treatment of high-risk early breast cancer patients
• Focus on the latest data from the clinical trials and how work up and treatment pathways may vary from country to country